These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1635320)

  • 41. Transient insomnia associated with a 3-hour phase advance of sleep time and treatment with zolpidem.
    Walsh JK; Schweitzer PK; Sugerman JL; Muehlbach MJ
    J Clin Psychopharmacol; 1990 Jun; 10(3):184-9. PubMed ID: 2198296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amplitude reduction of plasma melatonin rhythm in association with an internal desynchronization in a subject with non-24-hour sleep-wake syndrome.
    Masubuchi S; Hashimoto S; Endo T; Honma S; Honma K
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):249-51. PubMed ID: 10459702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical features of circadian rhythm sleep disorders in outpatients.
    Yamadera W; Sasaki M; Itoh H; Ozone M; Ushijima S
    Psychiatry Clin Neurosci; 1998 Jun; 52(3):311-6. PubMed ID: 9681583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed sleep phase syndrome response to melatonin.
    Dahlitz M; Alvarez B; Vignau J; English J; Arendt J; Parkes JD
    Lancet; 1991 May; 337(8750):1121-4. PubMed ID: 1674014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of melatonin to treat sleep disorders in tuberous sclerosis.
    O'Callaghan FJ; Clarke AA; Hancock E; Hunt A; Osborne JP
    Dev Med Child Neurol; 1999 Feb; 41(2):123-6. PubMed ID: 10075098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prostaglandin E2 and D2: opponents in the regulation of the sleep-wake rhythm?].
    Uhl D
    Med Monatsschr Pharm; 1990 Jan; 13(1):2-4. PubMed ID: 2304416
    [No Abstract]   [Full Text] [Related]  

  • 47. Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures.
    Fratello F; Curcio G; Ferrara M; Marzano C; Couyoumdjian A; Petrillo G; Bertini M; De Gennaro L
    Psychopharmacology (Berl); 2005 Oct; 181(4):761-70. PubMed ID: 15986193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The importance of timing in melatonin administration in a blind man.
    Tzischinsky O; Pal I; Epstein R; Dagan Y; Lavie P
    J Pineal Res; 1992 Apr; 12(3):105-8. PubMed ID: 1507054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lithium and wakefullness-sleep equilibrium in the cat].
    Lanoir J; Lardennois D
    Rev Electroencephalogr Neurophysiol Clin; 1976; 6(1):30-3. PubMed ID: 973034
    [No Abstract]   [Full Text] [Related]  

  • 50. Melatonin and circadian rhythms in autism: Case report.
    Zuculo GM; Gonçalves BSB; Brittes C; Menna-Barreto L; Pinato L
    Chronobiol Int; 2017; 34(4):527-530. PubMed ID: 28426389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benzodiazepine hypnotics: kinetic and therapeutic options.
    Greenblatt DJ; Divoll M; Abernethy DR; Shader RI
    Sleep; 1982; 5 Suppl 1():S18-27. PubMed ID: 6125022
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of vitamin B12 on the sleep-wake rhythm following an 8-hour advance of the light-dark cycle in the rat.
    Kiuchi T; Sei H; Seno H; Sano A; Morita Y
    Physiol Behav; 1997 Apr; 61(4):551-4. PubMed ID: 9108574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms.
    Lapierre O; Montplaisir J; Lamarre M; Bedard MA
    Sleep; 1990 Feb; 13(1):24-30. PubMed ID: 2406848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potassium affects actigraph-identified sleep.
    Drennan MD; Kripke DF; Klemfuss HA; Moore JD
    Sleep; 1991 Aug; 14(4):357-60. PubMed ID: 1947601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of a new alpha-2 adrenoceptor antagonist on sleep and nocturnal penile tumescence in normal male volunteers and men with erectile dysfunction.
    Bancroft J; Munoz M; Beard M; Shapiro C
    Psychosom Med; 1995; 57(4):345-56. PubMed ID: 7480564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis.
    Li T; Jiang S; Han M; Yang Z; Lv J; Deng C; Reiter RJ; Yang Y
    Front Neuroendocrinol; 2019 Jan; 52():22-28. PubMed ID: 29908879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sleepiness and nap sleep following a morning dose of clonidine.
    Carskadon MA; Cavallo A; Rosekind MR
    Sleep; 1989 Aug; 12(4):338-44. PubMed ID: 2762688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trials of bright light exposure and melatonin administration in a patient with non-24 hour sleep-wake syndrome.
    Hayakawa T; Kamei Y; Urata J; Shibui K; Ozaki S; Uchiyama M; Okawa M
    Psychiatry Clin Neurosci; 1998 Apr; 52(2):261-2. PubMed ID: 9628185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A review of sleep disorders and melatonin.
    Xie Z; Chen F; Li WA; Geng X; Li C; Meng X; Feng Y; Liu W; Yu F
    Neurol Res; 2017 Jun; 39(6):559-565. PubMed ID: 28460563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
    Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
    Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.